BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020;115:18-40. [PMID: 31895720 DOI: 10.14309/ajg.0000000000000486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Lawrence B, Siau K. Use of FFP to correct INR: time to drop this from the decompensated cirrhosis care bundle? Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102110] [Reference Citation Analysis]
2 Bos I, Blondeau M, Wouters D, Camus C, Houssel-Debry P, van der Plas WS, Nieuwenhuis LM, Bardou-Jacquet E, Lisman T, de Meijer VE, Porte RJ, Rayar M. Therapeutic anticoagulation after liver transplantation is not useful among patients with pre-transplant Yerdel-grade I/II portal vein thrombosis: A two-center retrospective study. J Thromb Haemost 2021. [PMID: 34297481 DOI: 10.1111/jth.15472] [Reference Citation Analysis]
3 La Mura V, Artoni A, Martinelli I, Rossio R, Gualtierotti R, Ghigliazza G, Fusco S, Ierardi AM, Andrisani MC, Carrafiello G, Peyvandi F. Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report. Am J Gastroenterol. 2020;115:1140-1142. [PMID: 32618673 DOI: 10.14309/ajg.0000000000000711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
4 Zanetto A, Rinder HM, Senzolo M, Simioni P, Garcia-Tsao G. Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis. Hepatol Commun 2021;5:272-82. [PMID: 33553974 DOI: 10.1002/hep4.1641] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Brown RS Jr, Imawari M, Izumi N, Osaki Y, Bentley R, Ochiai T, Kano T, Peck-Radosavljevic M. Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag. JHEP Rep 2021;3:100228. [PMID: 33644726 DOI: 10.1016/j.jhepr.2021.100228] [Reference Citation Analysis]
6 Kuroiwa Y, Kusumoto K, Shimata K, Yamashita A, Hibi T, Asada Y, Imamura T. MRI diffusion-weighted imaging detects a fresh portal vein thrombus as a high intensity lesion in a patient with a liver transplant: A case report. Acta Radiol Open 2021;10:20584601211069557. [PMID: 34992794 DOI: 10.1177/20584601211069557] [Reference Citation Analysis]
7 Riva N, Carrier M, Gatt A, Ageno W. Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey. Res Pract Thromb Haemost 2020;4:1192-202. [PMID: 33134784 DOI: 10.1002/rth2.12424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Alukal JJ, Zhang T, Thuluvath PJ. Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017). World J Hepatol 2021; 13(6): 686-698 [PMID: 34239703 DOI: 10.4254/wjh.v13.i6.686] [Reference Citation Analysis]
9 Roberts LN. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:485-91. [PMID: 34889414 DOI: 10.1182/hematology.2021000283] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kalbitz S, Ermisch J, Schmidt JM, Wallstabe I, Lübbert C. Unhappy Triad: Infection with Leptospira spp. Escherichia coli and Bacteroides uniformis Associated with an Unusual Manifestation of Portal Vein Thrombosis. Case Rep Gastroenterol 2021;15:598-602. [PMID: 34616262 DOI: 10.1159/000517094] [Reference Citation Analysis]
11 Sissingh NJ, Groen JV, Koole D, Klok FA, Boekestijn B, Bollen TL, van Santvoort HC, Verdonk RC, Bonsing BA, van Eijck CHJ, van Hooft JE, Mieog JSD; Dutch Pancreatitis Study Group. Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis. Pancreatology 2021:S1424-3903(21)00655-4. [PMID: 35012902 DOI: 10.1016/j.pan.2021.12.008] [Reference Citation Analysis]
12 Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Reference Citation Analysis]
14 Mancuso A, Amata M, Politi F, Mitra M, Marsala MGL, Maringhini A. Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness. Am J Gastroenterol 2020;115:952-3. [PMID: 32287138 DOI: 10.14309/ajg.0000000000000586] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Stotts MJ, Wentworth BJ, Northup PG. Management of Portal Vein Thrombosis in Cirrhosis. Semin Liver Dis 2021;41:79-86. [PMID: 33764487 DOI: 10.1055/s-0040-1722260] [Reference Citation Analysis]
16 Mansour N, Öcal O, Gerwing M, Köhler M, Deniz S, Heinzow H, Steib C, Angele MK, Seidensticker M, Ricke J, Wildgruber M. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access. Abdom Radiol. [DOI: 10.1007/s00261-022-03411-w] [Reference Citation Analysis]
17 Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study. Therap Adv Gastroenterol 2022;15:175628482210875. [DOI: 10.1177/17562848221087536] [Reference Citation Analysis]
18 Klok FA, Pai M, Huisman MV, Makris M. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol 2021:S2352-3026(21)00306-9. [PMID: 34774202 DOI: 10.1016/S2352-3026(21)00306-9] [Reference Citation Analysis]
19 Tosetti G, Farina E, Caccia R, Sorge A, Berzuini A, Valenti L, Prati D, Tripodi A, Lampertico P, Primignani M. Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian association for the study of the liver (AISF). Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.03.017] [Reference Citation Analysis]
20 Ballantine A, Martin D, Thakrar SV. The coagulopathy of liver disease: a shift in thinking. Br J Hosp Med (Lond) 2021;82:1-9. [PMID: 34191571 DOI: 10.12968/hmed.2021.0111] [Reference Citation Analysis]
21 Wei B, Huang Z, Tang C. Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein. Front Med 2022;9:853138. [DOI: 10.3389/fmed.2022.853138] [Reference Citation Analysis]
22 Alukal JJ, Zhang T, Thuluvath PJ. Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure. Am J Transplant. 2020;. [PMID: 33236517 DOI: 10.1111/ajt.16410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bridwell RE, Clerkin S, Walker NR, Long B, Goss S. Portal Venous Thrombosis in a Special Operations Paratrooper: A Case Report. Mil Med 2021:usab387. [PMID: 34591088 DOI: 10.1093/milmed/usab387] [Reference Citation Analysis]
24 Sinz S, Glaser-Gallion F, Steffen T. Portal vein thrombosis in COVID-19 infection. Surg Case Rep 2021;7:87. [PMID: 33830380 DOI: 10.1186/s40792-021-01173-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Luther J, Friedman LS. Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions. Clin Liver Dis 2022;26:1-12. [PMID: 34802655 DOI: 10.1016/j.cld.2021.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Klok FA, Barco S. Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark. Res Pract Thromb Haemost 2020;4:1080-2. [PMID: 33134773 DOI: 10.1002/rth2.12427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Gupta S, Hidalgo J, Singh B, Iyer A, Yang Y, Short A, Singh S, Bhatt H, Gupta S. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review. Cureus 2021;13:e16922. [PMID: 34367844 DOI: 10.7759/cureus.16922] [Reference Citation Analysis]
28 Riva N, Attard LM, Vella K, Squizzato A, Gatt A, Calleja-Agius J. Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis. Thromb Res 2021;207:102-12. [PMID: 34600286 DOI: 10.1016/j.thromres.2021.09.016] [Reference Citation Analysis]
29 Long MD, Bajaj JS. The American Journal of Gastroenterology in 2022 and Beyond: A Vision for "Our" Journal. Am J Gastroenterol 2021. [PMID: 34904963 DOI: 10.14309/ajg.0000000000001579] [Reference Citation Analysis]
30 Ageno W. Treatment of Atypical Clots. Hamostaseologie 2022;42:10-8. [PMID: 35196729 DOI: 10.1055/a-1669-3336] [Reference Citation Analysis]
31 Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-53. [PMID: 33930474 DOI: 10.1016/j.jhep.2021.04.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Roberts LN, Lisman T, Stanworth S, Hernandez-Gea V, Magnusson M, Tripodi A, Thachil J. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH. J Thromb Haemost 2021. [PMID: 34661370 DOI: 10.1111/jth.15562] [Reference Citation Analysis]
33 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
34 Riva N, Ageno W. Direct oral anticoagulants for unusual-site venous thromboembolism. Res Pract Thromb Haemost 2021;5:265-77. [PMID: 33733025 DOI: 10.1002/rth2.12480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. Am J Gastroenterol 2021;116:1447-64. [PMID: 33630766 DOI: 10.14309/ajg.0000000000001194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Reference Citation Analysis]
37 Wang L, Guo X, Xu X, Xu S, Han J, Wang R, Guo Z, Yi F, Qi X. No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis. Clin Appl Thromb Hemost 2021;27:10760296211010969. [PMID: 33882699 DOI: 10.1177/10760296211010969] [Reference Citation Analysis]
38 Xu S, Guo X, Yang B, Romeiro FG, Primignani M, Méndez-Sánchez N, Yoshida EM, Mancuso A, Tacke F, Noronha Ferreira C, De Stefano V, Qi X. Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review. Clin Transl Gastroenterol 2021;12:e00409. [PMID: 34597281 DOI: 10.14309/ctg.0000000000000409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Al Moosawi M, Trudeau J, Smith T, Lefebvre A, Shih AW. ROTEM in the setting of liver transplant surgery reduces frozen plasma transfusion. Transfus Apher Sci 2021;60:103125. [PMID: 33775554 DOI: 10.1016/j.transci.2021.103125] [Reference Citation Analysis]
40 Dong S, Qi H, Li Y, Men P, Alifu M, Zhang Y, Li Y, Zhao R. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat? Hepatol Int 2021. [PMID: 34487316 DOI: 10.1007/s12072-021-10233-3] [Reference Citation Analysis]
41 Giannini EG, Kano T, Ochiai T, Bentley R, Shrestha P, Afdhal N. Bleeding events in lusutrombopag-treated thrombocytopenic patients. Eur J Clin Invest 2021;51:e13503. [PMID: 33523482 DOI: 10.1111/eci.13503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 van Dam LF, Klok FA, Tushuizen ME, Ageno W, Darwish Murad S, van Haren GR, Huisman MV, Lauw MN, Iglesias Del Sol A, Wasser MNJM, Willink Y, Kroft LJM. Magnetic Resonance Thrombus Imaging to Differentiate Acute from Chronic Portal Vein Thrombosis. TH Open 2020;4:e224-30. [PMID: 32984756 DOI: 10.1055/s-0040-1716716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Magaz M, Alvarez-Larrán A, Colomer D, López M, Turon F, Cervantes F, Virginia-Hernández-Gea, García-Pagán JC. Reply to: Correspondence on "Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis". J Hepatol 2021;74:252-4. [PMID: 33012547 DOI: 10.1016/j.jhep.2020.09.009] [Reference Citation Analysis]